These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37364787)

  • 1. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
    Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
    Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
    Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders.
    Honkisz-Orzechowska E; Łażewska D; Baran G; Kieć-Kononowicz K
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18.
    Lipscomb M; Walis S; Marinello M; Mena HA; MacNamara KC; Spite M; Fredman G
    FASEB J; 2024 Mar; 38(6):e23555. PubMed ID: 38498346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron PA; Sharma AK; Upchurch GR
    FASEB J; 2024 Sep; 38(18):e70067. PubMed ID: 39320982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of resolvin D2 receptor mediating resolution of infections and organ protection.
    Chiang N; Dalli J; Colas RA; Serhan CN
    J Exp Med; 2015 Jul; 212(8):1203-17. PubMed ID: 26195725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR18 Agonist Resolvin D2 Reduces Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage by Multiple Protective Mechanisms.
    Zhang T; Zuo G; Zhang H
    Cell Mol Neurobiol; 2022 Oct; 42(7):2379-2392. PubMed ID: 34089427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
    Spite M; Fredman G
    Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
    Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
    Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18.
    Zhang LY; Liu ZH; Zhu Q; Wen S; Yang CX; Fu ZJ; Sun T
    Neurochem Res; 2018 Dec; 43(12):2384-2392. PubMed ID: 30443715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron P; Sharma AK; Upchurch GR
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis.
    Lipscomb M; Walis S; Marinello M; Mena HA; Spite M; Fredman G
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity.
    Pascoal LB; Bombassaro B; Ramalho AF; Coope A; Moura RF; Correa-da-Silva F; Ignacio-Souza L; Razolli D; de Oliveira D; Catharino R; Velloso LA
    J Neuroinflammation; 2017 Jan; 14(1):5. PubMed ID: 28086928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
    Chiang N; de la Rosa X; Libreros S; Serhan CN
    J Immunol; 2017 Jan; 198(2):842-851. PubMed ID: 27994074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats.
    Zuo G; Zhang D; Mu R; Shen H; Li X; Wang Z; Li H; Chen G
    Mol Brain; 2018 Feb; 11(1):9. PubMed ID: 29439730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.
    Lu Q; Yang Y; Zhang H; Chen C; Zhao J; Yang Z; Fan Y; Li L; Feng H; Zhu J; Yi S
    Drug Des Devel Ther; 2021; 15():4687-4699. PubMed ID: 34815664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities.
    Ulu A; Sahoo PK; Yuil-Valdes AG; Mukherjee M; Van Ormer M; Muthuraj PG; Thompson M; Anderson Berry A; Hanson CK; Natarajan SK; Nordgren TM
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Li C; Wan J; Wang M
    Front Immunol; 2022; 13():1053175. PubMed ID: 36518760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in Aging.
    Fitzgerald H; Bonin JL; Sadhu S; Lipscomb M; Biswas N; Decker C; Nabage M; Bossardi R; Marinello M; Mena AH; Gilliard K; Spite M; Adam A; MacNamara KC; Fredman G
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.
    Ye Y; Scheff NN; Bernabé D; Salvo E; Ono K; Liu C; Veeramachaneni R; Viet CT; Viet DT; Dolan JC; Schmidt BL
    Neuropharmacology; 2018 Sep; 139():182-193. PubMed ID: 30009833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.